NR1I3 and Other metabolic disease: With RXR, such as CAR, being involved in the pathogenesis of metabolic syndrome, the pan-activation of the permissive CAR/RXR heterodimer amplifies metabolic disorders induced by xenobiotics, as underlined by other authors [45].